Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.

News Releases

view all
    • News in Focus
        • Browse News Releases

        • All Public Company News
        • All Multimedia News
        • View All News Releases

        • Regulatory News

        • D/A/CH Regulatory News
        • UK Regulatory News
        • View All Regulatory News

    • Business & Money
        • Auto & Transportation

        • Aerospace & Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads & Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking & Road Transportation
        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film & Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers & Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalisation
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls & Research
        • Trade Show News
        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil & Gas Discoveries
        • Utilities
        • Water Utilities
        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defence
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation & Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking & Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers & Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines & Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics & Personal Care
        • Fashion
        • Food & Beverages
        • Furniture & Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewellery
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film & Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • View All Sports

        • Travel

        • Amusement Parks & Tourist Attractions
        • Gambling & Casinos
        • Hotels & Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Animal Welfare
        • Corporate Social Responsibility
        • Economic News, Trends & Analysis
        • Education
        • Environmental
        • European Government
        • Labour & Union
        • Natural Disasters
        • Not For Profit
        • Public Safety
        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Enquiries
    • Media Enquiries
    • Partnerships
    • Hamburger menu
    • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
    • Send a Release
      • Phone

      • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

      • ALL CONTACT INFO
      • Contact Us

        +44 (0)20 7454 5110
        from 8 AM - 5:30 PM GMT

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      • 2 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      • General Enquiries
      • Media Enquiries
      • Partnerships
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Regulatory News
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      LOTTE Biologics Holds Completion Ceremony for Songdo Bio Campus


      News provided by

      LOTTE Biologics

      18 Nov, 2026, 11:29 GMT

      Share this article

      Share this article


      "A New Horizon for K-Bio"

      • Completion ceremony for Plant 1 of the Songdo Bio Campus, securing a biopharmaceutical production facility with 120,000 liters of capacity
      • Leveraging large-scale production infrastructure and hands-on operating experience in the U.S., the company moves to strengthen its competitiveness in the global CDMO market

      INCHEON, South Korea, Nov. 18, 2026 /PRNewswire/ -- LOTTE Biologics (CEOs James Park and Yooyeol Shin) held a completion ceremony for Plant 1 at 10:00 a.m. on the 18th at the event venue within the Songdo Bio Campus in Incheon.

      Continue Reading
      This image opens in the lightbox
      Lotte Group Chairman Shin Dong-bin

      Approximately 300 distinguished guests from Korea and abroad attended, including Dong-bin Shin, Chairman of LOTTE Group; James Park, CEO of LOTTE Biologics; Yooyeol Shin, CEO of LOTTE Biologics; Park Chan-dae, Mayor of Incheon; Song Young-gil, National Assembly member for Incheon Yeonsu-gu (A); Jung Il-young, National Assembly member for Incheon Yeonsu-gu (B); and Jung Kyung-sil, Director General for Health and Medical Policy at the Ministry of Health and Welfare. Prime Minister Han Seong-sook also sent her congratulations by video.

      The ceremony began with a commemorative video and the pledge of allegiance, followed by opening remarks, a welcome address, and the screening of a company introduction video and congratulatory videos. Congratulatory speeches by key guests and a completion commemoration ceremony followed, after which attendees toured the main facilities of Plant 1 at the Songdo Bio Campus.

      In his remarks at the event, James Park, CEO of LOTTE Biologics, said, "Plant 1 of the Songdo Bio Campus achieved GMP Ready six months ahead of the original plan. This is the result of the efforts and dedication of all our employees, and it will serve as a solid foundation for growth as we take another step forward in the global market." He added, "Based on our new mission, 'relentless pursuit of perfection and sincere dedication to life,' we will grow into a company that contributes to patients' health and a better life for humanity."

      CEO Yooyeol Shin also said in his congratulatory remarks, "The completion of the Songdo Bio Campus is meaningful not only because it marks the completion of a new production facility, but because it lays the groundwork for LOTTE Biologics to contribute to strengthening the large-scale manufacturing capabilities of Korea's bio industry." He emphasized, "Under our new vision, 'The New Benchmark for Next Generation CDMOs,' we will be a CDMO partner that walks alongside our customers over the long term, built on the quality, technology, and trust they can truly feel."

      Dong-bin Shin, Chairman of LOTTE Group, said in his congratulatory remarks, "The bio business is LOTTE Group's future growth engine and a next-generation industry that will lead Korea's next generation. I hope Plant 1 of the Songdo Bio Campus will become an important turning point that goes beyond LOTTE Group's growth and raises the competitiveness of Korea's bio industry to the next level." He added, "Centered on Songdo, we will create quality jobs and nurture outstanding bio talent, while working closely with the government, related agencies, customers, and partners to contribute to the development of the domestic bio industry and the strengthening of national competitiveness."

      In a video message, Prime Minister Han Seong-sook said, "LOTTE Biologics' Songdo Plant 1 is the first fruit of LOTTE Group's bold, forward-looking investment in the bio industry, and it will bring new vitality to Korea's bio industry. I am confident that LOTTE Biologics will play an important role in Songdo's growth into a world-class biopharmaceutical production hub, and I hope it will lead the leap of K-Bio as a central pillar of the Songdo bio cluster."

      Incheon Mayor Park Chan-dae said in his congratulatory remarks, "Last April, as a candidate for mayor of Incheon, I announced my vision for Incheon's bio industry at the LOTTE Biologics construction site, so it is all the more meaningful to see that site completed as an actual production facility. LOTTE Biologics' Songdo Plant 1 is an important asset for Incheon's leap to becoming a center of the global bio industry. I am confident that Incheon's R&D and talent development foundation, combined with LOTTE Biologics' global production capabilities, will create synergy and raise the competitiveness of the bio industry."

      Plant 1 of the LOTTE Biologics Songdo Bio Campus, which broke ground in March 2024, has a total floor area of approximately 99,558 ㎡ and obtained its use approval in June 2026. It is equipped with major facilities including a production building, utility building, welfare building, and wastewater treatment plant, and has secured a total biopharmaceutical production capacity of 120,000 liters. The company explained that, following the use approval, it is carrying out preparatory procedures for commercial production, such as equipment qualification and validation, and plans to begin full-scale commercial production in 2027.

      The company stated that the completion of Plant 1 at the Songdo Bio Campus gives it a large-scale production base in Korea, following Syracuse in the United States. Building on this, it plans to accelerate its business strategy linking its production hubs in Korea and the U.S. and to expand its presence in the global CDMO market. End.

      Modal title

      Also from this source

      LOTTE Biologics Secures Major Commercial Manufacturing Agreement Ahead of Songdo Plant 1 Launch

      LOTTE Biologics Secures Major Commercial Manufacturing Agreement Ahead of Songdo Plant 1 Launch

      LOTTE Biologics (Co-CEOs James Park and Yoo-yeol Shin) today announced a major commercial manufacturing agreement with a global pharmaceutical...

      LOTTE Biologics Expands Antibody Manufacturing Agreement with Ottimo Pharma

      LOTTE Biologics Expands Antibody Manufacturing Agreement with Ottimo Pharma

      LOTTE Biologics (Co-CEOs James Park and Yooyeol Shin) announce an expansion of its collaboration with Ottimo Pharma, an innovative biotech company...

      More Releases From This Source

      Explore

      Health Care & Hospitals

      Health Care & Hospitals

      Pharmaceuticals

      Pharmaceuticals

      Medical Pharmaceuticals

      Medical Pharmaceuticals

      Biotechnology

      Biotechnology

      News Releases in Similar Topics

      Contact PR Newswire

      • +44 (0)20 7454 5110
        from 8 AM - 5:30 PM GMT
      • General Enquiries
      • Media Enquiries
      • Partnerships

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United States
      • Vietnam

      My Services

      • All News Releases
      • PR Newswire Amplify™
      • Resources
      • Journalists
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via Privacy@cision.com 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Customer Portal
      • Resources
      • Journalists
      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookie Settings
      Copyright © 2026 PR Newswire Europe Limited. All Rights Reserved. A Cision company.